COI
NVO

Connable Office Inc’s Novo Nordisk NVO Stock Holding History

Connable Office Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,209
Closed -$621K – 247
2025
Q4 		$621K Hold
12,209
– – 0.06% 127
2025
Q3 		$677K Hold
12,209
– – 0.06% 115
2025
Q2 		$843K Sell
12,209
-7,929
-39% -$539K 0.08% 100
2025
Q1 		$1.4M Sell
20,138
-1,030
-5% -$85.1K 0.15% 82
2024
Q4 		$1.82M Hold
21,168
– – 0.19% 72
2024
Q3 		$2.52M Hold
21,168
– – 0.25% 63
2024
Q2 		$3.02M Sell
21,168
-1,178
-5% -$156K 0.33% 46
2024
Q1 		$2.87M Sell
22,346
-423
-2% -$50.4K 0.33% 54
2023
Q4 		$2.36M Sell
22,769
-925
-4% -$91.5K 0.29% 65
2023
Q3 		$2.15M Buy
23,694
+58
+0.2% +$5.11K 0.3% 63
2023
Q2 		$1.91M Sell
23,636
-156
-0.7% -$12.7K 0.26% 68
2023
Q1 		$1.89M Sell
23,792
-418
-2% -$29.6K 0.28% 70
2022
Q4 		$1.64M Buy
24,210
+62
+0.3% +$3.63K 0.23% 74
2022
Q3 		$1.2M Hold
24,148
– – 0.2% 80
2022
Q2 		$1.34M Buy
24,148
+6,282
+35% +$349K 0.21% 78
2022
Q1 		$992K Buy
17,866
+1,850
+12% +$94.9K 0.13% 91
2021
Q4 		$897K Buy
+16,016
New +$868K 0.11% 108
2016
Q3 		– Sell
-13,770
Closed -$370K – 217
2016
Q2 		$370K Buy
13,770
+1,070
+8% +$29.3K 0.1% 99
2016
Q1 		$344K Hold
12,700
– – 0.1% 107
2015
Q4 		$369K Sell
12,700
-1,300
-9% -$36K 0.11% 107
2015
Q3 		$380K Sell
14,000
-1,214
-8% -$34.4K 0.11% 100
2015
Q2 		$417K Buy
15,214
+1,114
+8% +$31.3K 0.11% 96
2015
Q1 		$376K Hold
14,100
– – 0.1% 110
2014
Q4 		$298K Sell
14,100
-8,600
-38% -$192K 0.08% 127
2014
Q3 		$540K Sell
22,700
-6,500
-22% -$150K 0.14% 82
2014
Q2 		$674K Sell
29,200
-1,200
-4% -$26.5K 0.17% 76
2014
Q1 		$694K Hold
30,400
– – 0.19% 74
2013
Q4 		$562K Buy
30,400
+11,900
+64% +$207K 0.15% 83
2013
Q3 		$313K Buy
+18,500
New +$311K 0.09% 164

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Connable Office Inc's NVO Position: Q1 2026 in Review

Connable Office Inc sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 12,209 shares — an estimated $621K sold.

Connable Office Inc first reported a position in NVO in Q3 2013 and held it in 29 quarters. The position peaked at $3.02M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Connable Office Inc reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Connable Office Inc sold 12,209 Novo Nordisk shares in Q1 2026, an estimated $621K.
  • Connable Office Inc first reported a position in Novo Nordisk in Q3 2013 and held it in 29 quarters.
  • Connable Office Inc's Novo Nordisk position peaked at $3.02M in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Connable Office Inc's 13F filing for Q1 2026, filed 29 Apr 2026.